Quercetin Promotes the Osteogenic Differentiation of Rat Mesenchymal Stem Cells Via Mitogen-activated Protein Kinase Signaling

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2015 Jul 3

PMID 26136938

Citations 24

Authors

Yang Li

Jiefang Wang

Guangming Chen

Shuiwang Feng

Panpan Wang

Xiaofeng Zhu

Ronghua Zhang

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the effects of quercetin on the mitogen-activated protein kinase (MAPK) signaling pathway in the osteogenic differentiation of rat mesenchymal stem cells (MSCs). A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and an alkaline phosphatase (ALP) assay were used to determine the effects of quercetin (concentrations of 0.1, 1 and 10 µmol/l) on the proliferation and differentiation of MSCs and the expression of ALP, respectively. In addition, through the introduction of inhibitors of p38 MAPK, extracellular signal-regulated kinase (ERK)1/2 and c-Jun NH-terminal kinase (JNK), the effects of quercetin on the proteins, ALP, collagen type I (COL I) and bone γ-carboxyglutamate protein (BGP), which are indicators of osteogenic differentiation, were investigated. Immunoblotting was performed to determine the phosphorylation levels of p38 MAPK, ERK1/2 and JNK, while fluorescent quantitative polymerase chain reaction was used to determine the mRNA expression levels of transforming growth factor (TGF)-β1, bone morphogenetic protein (BMP)-2 and core binding factor (CBF)α1. At all the concentrations tested, the concentrations of 10, 1 and 0.1 µmol/l quercetin were shown to promote the differentiation of MSCs and the expression of ALP, in which the concentration of 10 µmol/l was optimal. When compared with the control group, the phosphorylation levels of p38 MAPK, ERK1/2 and JNK, the protein expression levels of ALP, COL I and BGP, and the mNRA expression levels of TGF-β1, BMP-2 and Cbfα1 were increased in the quercetin-treated group. However, with the introduction of inhibitors, the levels of phosphorylated p38 MAPK, ERK1/2 and JNK, and the protein expression levels of ALP, COL I and BGP decreased. Furthermore, the mRNA expression levels of TGF-β1, BMP-2 and CBFα1 decreased in the quercetin + SP600125 (inhibitor of JNK) and quercetin + PD98059 (inhibitor of ERK1/2) groups. Therefore, quercetin was demonstrated to promote the osteogenic differentiation of MSCs by activating the MAPK signaling pathway. The ERK1/2 and JNK signaling pathways regulate the expression of TGF-β1, BMP-2 and CBFα1. Thus, activation of the ERK1/2 and JNK signaling pathways may play a leading role in the quercetin-promoted osteogenic proliferation and differentiation of MSCs.

Citing Articles

Synthesis and Characterization of a Strontium-Quercetin Complex and Its In Vitro and In Vivo Potential for Application in Bone Regeneration.

Pimenta I, Chaves Filho G, Silva E, Nogueira L, de Mendonca T, Furtado T ACS Omega. 2025; 10(5):4836-4846.

PMID: 39959088 PMC: 11822716. DOI: 10.1021/acsomega.4c09949.

Quercetin-Loaded Bioglass Injectable Hydrogel Promotes m6A Alteration of Per1 to Alleviate Oxidative Stress for Periodontal Bone Defects.

Zhu H, Cai C, Yu Y, Zhou Y, Yang S, Hu Y Adv Sci (Weinh). 2024; 11(29):e2403412.

PMID: 38749005 PMC: 11304245. DOI: 10.1002/advs.202403412.

Quercetin suppresses ovariectomy-induced osteoporosis in rat mandibles by regulating autophagy and the NLRP3 pathway.

Xiong Y, Huang C, Shi C, Peng L, Cheng Y, Hong W Exp Biol Med (Maywood). 2024; 248(23):2363-2380.

PMID: 38240215 PMC: 10903250. DOI: 10.1177/15353702231211977.

: a potential herb for treatment of osteoporosis.

Tang X, Huang Y, Fang X, Tong X, Yu Q, Zheng W Front Med (Lausanne). 2023; 10:1289144.

PMID: 38111697 PMC: 10725965. DOI: 10.3389/fmed.2023.1289144.

Pro-Osteogenic and Anti-Inflammatory Synergistic Effect of Orthosilicic Acid, Vitamin K2, Curcumin, Polydatin and Quercetin Combination in Young and Senescent Bone Marrow-Derived Mesenchymal Stromal Cells.

Giordani C, Matacchione G, Giuliani A, Valli D, Scarpa E, Antonelli A Int J Mol Sci. 2023; 24(10).

PMID: 37240169 PMC: 10218531. DOI: 10.3390/ijms24108820.

References

Palcy S, Goltzman D . Protein kinase signalling pathways involved in the up-regulation of the rat alpha1(I) collagen gene by transforming growth factor beta1 and bone morphogenetic protein 2 in osteoblastic cells. Biochem J. 1999; 343 Pt 1:21-7. PMC: 1220519. View

Tian H, Bi X, Li C, Zhao K, Brochmann E, Montgomery S . Secreted phosphoprotein 24 kD (Spp24) and Spp14 affect TGF-β induced bone formation differently. PLoS One. 2013; 8(8):e72645. PMC: 3753320. DOI: 10.1371/journal.pone.0072645. View

Yamaguchi M, Weitzmann M . Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts. Int J Mol Med. 2011; 28(4):521-5. DOI: 10.3892/ijmm.2011.749. View

Sharan K, Mishra J, Swarnkar G, Siddiqui J, Khan K, Kumari R . A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action. J Bone Miner Res. 2011; 26(9):2096-111. DOI: 10.1002/jbmr.434. View

Jung C, Cho I, Ahn J, Jeon T, Ha T . Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res. 2012; 27(1):139-43. DOI: 10.1002/ptr.4687. View

Zhang H, Zhang M, Yu L, Zhao Y, He N, Yang X . Antitumor activities of quercetin and quercetin-5',8-disulfonate in human colon and breast cancer cell lines. Food Chem Toxicol. 2012; 50(5):1589-99. DOI: 10.1016/j.fct.2012.01.025. View

Fu L, Tang T, Miao Y, Zhang S, Qu Z, Dai K . Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation. Bone. 2008; 43(1):40-47. DOI: 10.1016/j.bone.2008.03.008. View

Liang W, Luo Z, Ge S, Li M, Du J, Yang M . Oral administration of quercetin inhibits bone loss in rat model of diabetic osteopenia. Eur J Pharmacol. 2011; 670(1):317-24. DOI: 10.1016/j.ejphar.2011.08.014. View

Park Y, Lee J, Shin S, Kim Y . Constitutively active Ras negatively regulates Erk MAP kinase through induction of MAP kinase phosphatase 3 (MKP3) in NIH3T3 cells. BMB Rep. 2014; 47(12):685-90. PMC: 4345513. DOI: 10.5483/bmbrep.2014.47.12.017. View

10.

Niklas J, Nonnenmacher Y, Rose T, Sandig V, Heinzle E . Quercetin treatment changes fluxes in the primary metabolism and increases culture longevity and recombinant α₁-antitrypsin production in human AGE1.HN cells. Appl Microbiol Biotechnol. 2011; 94(1):57-67. DOI: 10.1007/s00253-011-3811-4. View

11.

Yamaguchi A, Komori T, Suda T . Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev. 2000; 21(4):393-411. DOI: 10.1210/edrv.21.4.0403. View

12.

Takeda S, Bonnamy J, Owen M, Ducy P, Karsenty G . Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 2001; 15(4):467-81. PMC: 312629. DOI: 10.1101/gad.845101. View

13.

Hadjidakis D, Androulakis I . Bone remodeling. Ann N Y Acad Sci. 2007; 1092:385-96. DOI: 10.1196/annals.1365.035. View

14.

Lee J, Roh K, Kim S, Lee J, Park D . Soy peptide-induced stem cell proliferation: involvement of ERK and TGF-β1. J Nutr Biochem. 2012; 23(10):1341-51. DOI: 10.1016/j.jnutbio.2011.08.003. View

15.

Peng S, Zhou G, Luk K, Cheung K, Li Z, Lam W . Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Cell Physiol Biochem. 2009; 23(1-3):165-74. DOI: 10.1159/000204105. View

16.

Zhou H, Yang X, Wang N, Zhang Y, Cai G . Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells. Mol Cell Endocrinol. 2007; 270(1-2):17-22. DOI: 10.1016/j.mce.2007.01.017. View

17.

Wang Y, Li J, Wang Y, Lei L, Jiang C, An S . Effects of hypoxia on osteogenic differentiation of rat bone marrow mesenchymal stem cells. Mol Cell Biochem. 2011; 362(1-2):25-33. DOI: 10.1007/s11010-011-1124-7. View

18.

Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J . Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res. 2003; 18(11):2060-8. DOI: 10.1359/jbmr.2003.18.11.2060. View

19.

Palcy S, Bolivar I, Goltzman D . Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells. J Bone Miner Res. 2000; 15(12):2352-61. DOI: 10.1359/jbmr.2000.15.12.2352. View

20.

Wong M, Chiu G . Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine. 2011; 7(6):834-40. DOI: 10.1016/j.nano.2011.02.001. View